Nucleic Acid Therapeutics Initiative (NATi) Executive Director Dr Mohamed ElSayed Ph.D. will be participating as a panelist at RNA World 2026 in Shanghai, China.
Public source
Publisher name
Public post
📍 See you at RNA World 2026 at Shanghai, China! The Nucleic Acid Therapeutics Initiative (NATi) is proud to be part of the conversation shaping the future of RNA therap…
Company
Nucleic Acid Therapeutics Initiative (NATi)
Innovating for Better RNA Medicines
- Industry
- Biotechnology Research
- Location
- Singapore, SG
- Company size
- 11–50 employees
About Nucleic Acid Therapeutics Initiative (NATi)
The Nucleic Acid Therapeutics Initiative (NATi) is a national platform that aims to build Singapore into a regional hub for nucleic acid therapeutics (NAT) research, clinical translation, and commercialisation. NATi harnesses the potential of nucleic acids to treat diseases using RNA molecules. This initiative bolsters strategic partnerships and propels healthcare innovations, benefitting Singapore and Singaporeans.
See moreLatest activity
Latest activity from Nucleic Acid Therapeutics Initiative (NATi)
4 signals
Presence & Recognition
Nucleic Acid Therapeutics Initiative (NATi) participated in the RNA Leaders APAC 2026 event, attending sessions and meeting with researchers, biotech companies, technology providers, investors, and ecosystem partners.
Presence & Recognition
Nucleic Acid Therapeutics Initiative (NATi) participated in the RNA Leaders APAC 2026 event, attending sessions and meeting with researchers, biotech companies, technology providers, investors, and ecosystem partners.
Presence & Recognition
Nucleic Acid Therapeutics Initiative (NATi) Executive Director Mohamed ElSayed delivered an opening address at the RNA Leaders APAC 2026 event in Singapore.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
CREATE Medicines
CREATE Medicines will present at RNA World 2026 in Shanghai, September 10-11.
Presence & Recognition
Inside Therapeutics (InsideTx)
Inside Therapeutics (InsideTx) will host RNA World 2026 in Shanghai, China, from September 10-11, 2026, featuring plenary symposia, workshops, and a packed abstract program.
Presence & Recognition
Synoligo Biotechnologies Inc
Synoligo Biotechnologies Inc is exhibiting at the RNA Horizons Conference 2026 in Munich from September 16-18.
Presence & Recognition
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is co-organizing the RNA at the Bench and Bedside V conference with Nature Portfolio, Nature Biotechnology, Ionis Pharmaceuticals, Inc., and UC San Diego Center for RNA Technologies and Therapeutics.
Presence & Recognition
Nona Biosciences